Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$3.68 USD
-0.29 (-7.30%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $3.67 -0.01 (-0.27%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.11 | 0.00% |
Earnings Summary
For their last quarter, Corvus Pharmaceuticals (CRVS) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.12 per share. This reflects a positive earnings surprise of 41.67%. Look out for CRVS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 8.33%.
Earnings History
Price & Consensus
Zacks News for CRVS
Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
CRVS: What are Zacks experts saying now?
Zacks Private Portfolio Services